Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. - Wikidata - awgldk - TriplyDB

Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy.

Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy.

http://www.wikidata.org/entity/Q34608120

about

The immunogenetics of Behçet's disease: A comprehensive review Relationship between serum interleukin-1beta levels and acute phase response proteins in patients with familial Mediterranean fever Safety and tolerability of the T-cell depletion protocol coupled with anakinra and etanercept for clinical islet cell transplantation.Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever Increased levels of circulating Annexin A5 in Familial Mediterranean fever.The contribution of SAA1 polymorphisms to Familial Mediterranean fever susceptibility in the Japanese population.Inflammasomes and their activation.Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice.High Frequency of Inherited Variants in the MEFV Gene in Acute Lymphocytic Leukemia.Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment Increased oxidative stress in patients with familial Mediterranean fever during attack period.Identification of Disease-Promoting HLA Class I and Protective Class II Modifiers in Japanese Patients with Familial Mediterranean Fever.Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.Live and inactivated Salmonella enterica serovar Typhimurium stimulate similar but distinct transcriptome profiles in bovine macrophages and dendritic cells Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.Distribution of MEFV gene mutations and R202Q polymorphism in the Serbian population and their influence on oxidative stress and clinical manifestations of inflammation.Biological treatments: new weapons in the management of monogenic autoinflammatory disorders A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD).Monogenic autoinflammatory diseases: concept and clinical manifestations.Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation Familial Mediterranean fever: An updated review.Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.Treating inflammation by blocking interleukin-1 in humans.Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.Vascular comorbidities in familial Mediterranean fever.The regulation of MEFV expression and its role in health and familial Mediterranean fever.High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility?IL-1β biological treatment of familial Mediterranean fever.Coexistence of Behçet's disease with ankylosing spondylitis and familial Mediterranean fever: a rare occurrence Genetically defined autoinflammatory diseases.An Up-to-date Approach to a Patient with a Suspected Autoinflammatory Disease.Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study.Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation.Frequencies of the Common MEFV Gene Mutations in Adiyaman, Southeast Anatolia, Turkey.Familial Mediterranean fever-associated diseases in children.IL-1β and Caspase-1 Drive Autoinflammatory Disease Independently of IL-1α or Caspase-8 in a Mouse Model of Familial Mediterranean Fever.Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.Investigation of the Levels of Serum Amyloid A, YKL-40, and Pentraxin-3 in Patients with Familial Mediterranean Fever.Correlation of Secretory Activity of Neutrophils With Genotype in Patients With Familial Mediterranean Fever.A variant allele of the Mediterranean-fever gene increases the severity of gout.

P2860

Q28088324-86171204-70CC-43F1-9808-64B88A78209B Q33773150-CED04242-7914-421F-9536-0A1CED9821F3 Q33848529-0416D4A0-06C9-4CED-A112-F02FF330BC01 Q33984080-B1CC829B-4AE7-43EE-B367-298B121B98CD Q34410408-AE319F26-CBD0-48C0-80E3-1C369A46202D Q34598115-5C02FC5F-8428-41EB-9B94-3C736C88BD78 Q34905606-A66020C6-AFC4-4D36-A575-85D144496D47 Q35086225-4206828C-ABDD-4F69-A79C-6B84F33B9CEB Q35163232-3B4FDF06-E5B9-485B-A1E9-8E0969014D1C Q35535362-0B8D40E7-E77B-41CE-8DD5-0BE8DA12307E Q35561637-F46FB5B5-70F6-46D9-A56D-05F4E40FBA6B Q35606855-462422D2-A9F1-4E10-9637-34EF4615D2F5 Q36041225-84C1EBE4-F84A-48DF-9C91-A626CA4638E4 Q36714363-EEB4EEA7-1458-42CF-84E8-3CFEEA6E2793 Q36816872-18BFA443-49A5-49F5-AA66-EB19F1037732 Q37057769-A982C1CB-845F-4EA5-9F96-316C87FB299B Q37077564-52092D0C-C4D4-43C5-AD06-E273028FECC9 Q37142757-43F6817D-4957-4BE7-BE39-8B8A1F59E52F Q37162157-451D758C-C113-4013-BC29-16F72FB6858C Q37200090-5BA7F046-6C1C-4663-91FB-46855DD1E9BE Q37296449-26F79251-535A-4C5E-9365-93847978CF67 Q37466515-55232317-88B4-4DFC-8D0C-208524962BE1 Q37636664-DC4F0E34-3FC5-4A87-94D9-3B55A09AD150 Q37808103-090B905A-EB2E-4E00-B729-8C8541C01B4C Q37857761-DD4443B7-2D0B-4502-ACF0-787592B5D9B0 Q37903230-6DFB9AD6-6526-4A95-BEC0-7FDFD8237409 Q37997663-7BD24CC3-709A-41E8-A3B4-571535EE5E3E Q38074355-262FAF11-303D-40E5-BAE8-77B7B196A258 Q38679038-134BAE88-3B09-4018-A268-3FDE0C649F8B Q38720044-9288F82B-7F84-485C-AECF-BFE928C0588B Q39126636-F737FB1D-C065-4BCA-84D7-00FB358EBD8A Q39829020-275F29D5-047E-42BB-BF98-775F97AC6C1E Q39845776-10AA9C12-E967-4B5A-8763-E33CE0077164 Q40044592-6C7511AA-1D5F-4F62-A4A9-BE2851B6952D Q40074680-D4CC46D4-F552-4F28-9783-779A1F8EBFDC Q40075783-F32BA3BE-5F47-4A54-807D-457B2827E158 Q40079604-33273830-19CE-4658-ACB8-61733E09F015 Q40082880-5C40B709-E101-440E-9184-4E160C718916 Q40100206-872951A6-42DD-427E-B165-FF598985748F Q40108109-5F8C8DED-6AA2-4F07-8EFD-334AAE9F46F1

P2860

Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy.

http://www.wikidata.org/entity/Q34608120

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Advances in the understanding ...... bilities for targeted therapy.

@ast

Advances in the understanding ...... bilities for targeted therapy.

@en

Advances in the understanding ...... bilities for targeted therapy.

@nl

type

label

Advances in the understanding ...... bilities for targeted therapy.

@ast

Advances in the understanding ...... bilities for targeted therapy.

@en

Advances in the understanding ...... bilities for targeted therapy.

@nl

prefLabel

Advances in the understanding ...... bilities for targeted therapy.

@ast

Advances in the understanding ...... bilities for targeted therapy.

@en

Advances in the understanding ...... bilities for targeted therapy.

@nl

P1433

Q34608120-BD252FA5-E8E2-4C7E-953D-3B220C0D678A

P1476

Q34608120-E17000B2-AC18-4132-9CCA-15F442E8D1D7

P2093

Q34608120-492E8D99-B174-4184-B8BF-EE8CCC981E18

Q34608120-B147F51C-2D10-4F61-B25A-C583D72959C8

Q34608120-C062E6C0-E9A6-4CF4-892A-0380D3213AC0

P2860

Q34608120-0C89A30E-DE3C-4A15-9820-70CD4E6226F5

Q34608120-16FFFEEE-048A-4AA6-86A3-0BA72B6F0109

Q34608120-178FD27B-1C09-4DD5-B67F-13EE9155760E

Q34608120-195A97E4-DA40-4CBF-A88D-A8419771313F

Q34608120-19C082CB-4856-42FE-94B7-927B00EEE0E9

Q34608120-1DF3C586-148A-4EF3-B12F-CE0B8E935817

Q34608120-203BDD5D-AEF3-48E1-8B67-AF7EF23BBC1E

Q34608120-2379E5A9-89A1-4A38-8CD0-BF832FDD9B8D

Q34608120-24BDF763-06A0-4D2B-BCD1-AF5F7AE061A5

Q34608120-25BD1790-3D36-44F5-B381-B2E235BD10B1

P304

Q34608120-D7B13026-7B5A-441E-806A-546BDB6FBE2B

P31

Q34608120-6996EEF0-FEA0-437B-BAEE-3000CE19DA2C

P356

Q34608120-F6219958-F61E-47E5-AB10-C323E6F4DF60

P407

Q34608120-1C695778-4308-4742-96DD-08B836272842

P433

Q34608120-B46E354A-42CD-4250-87C3-4AD1FEB99ED2

P478

Q34608120-1D71EFBD-3036-47F1-8F47-92C69C95AD81

P577

Q34608120-48F19C8F-F595-4C37-98A1-17A2B4BD556D

P5875

Q34608120-060E1D26-8D3A-40BA-A164-B276AEE35915

P698

Q34608120-26221EA1-09A7-4518-B2EE-4455CB011BCD

P932

Q34608120-B88AD298-F816-4C18-BF25-21144CC31258

P356

J.1365-2141.2009.07733.X

P1433

British Journal of Haematology

P1476

Advances in the understanding ...... bilities for targeted therapy.

@en

P2093

Daniel L Kastner

http://www.w3.org/2001/XMLSchema#string

Ivona Aksentijevich

http://www.w3.org/2001/XMLSchema#string

Jae J Chae

http://www.w3.org/2001/XMLSchema#string

P2860

ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells

Impairment of NF-kB activation and modulation of gene expression by calpastatin

Alternative splicing at the MEFV locus involved in familial Mediterranean fever regulates translocation of the marenostrin/pyrin protein to the nucleus

ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology

The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B

PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing

ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis

The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation

P304

467-478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2009.07733.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26238528

http://www.w3.org/2001/XMLSchema#string

P698

19466978

http://www.w3.org/2001/XMLSchema#string

P932

2759843

http://www.w3.org/2001/XMLSchema#string